Kwality Pharmaceuticals Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

888.00 +49.80 (5.94%)Updated : 12 Nov 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	308.10	267.48	222.38	295.21
Other Net	1.65	1.83	2.89	3.51
Diluted Weighted Average Shares	1.04	1.04	1.04	1.04
Gain( Loss)on Saleof Assets	0.03	0.00	0.05	-
Depreciation/ Amortization	18.29	19.56	14.96	10.69
Operating Income	62.10	39.69	28.65	160.97
Net Income	39.85	23.80	19.37	119.99
Income Availableto Com Excl Extra Ord	39.85	23.80	19.37	119.99
Other Operating Expenses Total	0.03	-	50.86	63.77
Net Income Before Taxes	54.14	31.10	25.57	161.57
Minority Interest	0.04	0.18	0.09	0.05
Net Income After Taxes	39.80	23.62	19.28	119.94
Income Availableto Com Incl Extra Ord	39.85	23.80	19.37	119.99
Costof Revenue Total	182.49	153.18	110.07	200.60
Gross Profit	187.71	153.99	140.96	255.58
Interest Inc( Exp) Net- Non- Op Total	-9.63	-10.42	-6.02	-2.92
Unusual Expense( Income)	0.00	7.10	16.53	-
Diluted Net Income	39.85	23.80	19.37	119.99
Provisionfor Income Taxes	14.34	7.48	6.29	41.63
period Type	-	-	-	-
Net Income Before Extra Items	39.85	23.80	19.37	119.99
Total Revenue	370.20	307.17	251.03	456.19
period Length	12.00	12.00	12.00	12.00
Revenue	370.20	307.17	251.03	456.19
Selling/ General/ Admin Expenses Total	107.29	87.64	29.96	20.15
Diluted Normalized EPS	38.38	28.13	30.64	115.64
Diluted EPS Excluding Extra Ord Items	38.40	22.93	18.67	115.64
Total Adjustmentsto Net Income	-	-	0.00	0.00